PMC:7408073 / 59539-59773 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"2124","span":{"begin":31,"end":35},"obj":"Gene"},{"id":"2125","span":{"begin":69,"end":72},"obj":"Gene"},{"id":"2127","span":{"begin":41,"end":44},"obj":"Gene"},{"id":"2134","span":{"begin":143,"end":147},"obj":"Species"},{"id":"2138","span":{"begin":111,"end":125},"obj":"Chemical"},{"id":"2144","span":{"begin":74,"end":85},"obj":"Disease"},{"id":"2145","span":{"begin":90,"end":107},"obj":"Disease"},{"id":"2146","span":{"begin":134,"end":142},"obj":"Disease"},{"id":"2147","span":{"begin":208,"end":216},"obj":"Disease"}],"attributes":[{"id":"A2124","pred":"tao:has_database_id","subj":"2124","obj":"Gene:70008"},{"id":"A2125","pred":"tao:has_database_id","subj":"2125","obj":"Gene:70008"},{"id":"A2127","pred":"tao:has_database_id","subj":"2127","obj":"Gene:69563"},{"id":"A2134","pred":"tao:has_database_id","subj":"2134","obj":"Tax:10090"},{"id":"A2138","pred":"tao:has_database_id","subj":"2138","obj":"MESH:D013311"},{"id":"A2144","pred":"tao:has_database_id","subj":"2144","obj":"MESH:D000419"},{"id":"A2145","pred":"tao:has_database_id","subj":"2145","obj":"MESH:D007674"},{"id":"A2146","pred":"tao:has_database_id","subj":"2146","obj":"MESH:D003920"},{"id":"A2147","pred":"tao:has_database_id","subj":"2147","obj":"MESH:D003920"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Finally, chronic inhibition of ACE2 with MLN-4760 led to increase of ACE, albuminuria and glomerular injury in streptozotocin-induced diabetic mice, indicating a possible adverse effect of the inhibitor in a diabetic background [119]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T315","span":{"begin":101,"end":107},"obj":"Disease"}],"attributes":[{"id":"A315","pred":"mondo_id","subj":"T315","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"}],"text":"Finally, chronic inhibition of ACE2 with MLN-4760 led to increase of ACE, albuminuria and glomerular injury in streptozotocin-induced diabetic mice, indicating a possible adverse effect of the inhibitor in a diabetic background [119]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T739","span":{"begin":160,"end":161},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T740","span":{"begin":206,"end":207},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Finally, chronic inhibition of ACE2 with MLN-4760 led to increase of ACE, albuminuria and glomerular injury in streptozotocin-induced diabetic mice, indicating a possible adverse effect of the inhibitor in a diabetic background [119]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T43819","span":{"begin":193,"end":202},"obj":"Chemical"}],"attributes":[{"id":"A57570","pred":"chebi_id","subj":"T43819","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"Finally, chronic inhibition of ACE2 with MLN-4760 led to increase of ACE, albuminuria and glomerular injury in streptozotocin-induced diabetic mice, indicating a possible adverse effect of the inhibitor in a diabetic background [119]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T285","span":{"begin":0,"end":234},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Finally, chronic inhibition of ACE2 with MLN-4760 led to increase of ACE, albuminuria and glomerular injury in streptozotocin-induced diabetic mice, indicating a possible adverse effect of the inhibitor in a diabetic background [119]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T96","span":{"begin":74,"end":85},"obj":"Phenotype"}],"attributes":[{"id":"A96","pred":"hp_id","subj":"T96","obj":"http://purl.obolibrary.org/obo/HP_0012592"}],"text":"Finally, chronic inhibition of ACE2 with MLN-4760 led to increase of ACE, albuminuria and glomerular injury in streptozotocin-induced diabetic mice, indicating a possible adverse effect of the inhibitor in a diabetic background [119]."}

{"project":"2_test","denotations":[{"id":"32708755-17579661-20678865","span":{"begin":229,"end":232},"obj":"17579661"}],"text":"Finally, chronic inhibition of ACE2 with MLN-4760 led to increase of ACE, albuminuria and glomerular injury in streptozotocin-induced diabetic mice, indicating a possible adverse effect of the inhibitor in a diabetic background [119]."}